Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud Rent for 48h to view Buy Cloud Access for unlimited viewing via different devices Synchronizing in the ReadCube Cloud Printing and saving restrictions apply Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: December 20, 2021
Accepted: February 14, 2022
Published online: February 22, 2022

Number of Print Pages: 9
Number of Figures: 4
Number of Tables: 2

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: https://www.karger.com/DDI

Abstract

Background: Acute liver failure (ALF) occurs as a rare, sudden, extensive loss of liver function in a previously healthy liver. In advanced cases, ALF may require liver transplantation (LT). Available prognostic parameters have limited accuracy to decide, which patient to consider for LT. The liver maximum function capacity test (LiMAx) can accurately determine liver function and was assessed as predictor of survival, along with coagulation parameters and liver stiffness in nonacetaminophen-induced ALF. Methods: Various liver function tests, including LiMAx measurements, coagulation factors, and transient elastography (TE), were analyzed retrospectively for associations with clinical outcome in 34 patients with ALF or acute hepatitis (AH). Data were compared between patients with spontaneous recovery (SR) and non-SR (3-month mortality/LT; NSR). Results: The analysis included 34 patients (22 ALF, 12 AH; 19 males, 15 females; age 36.7 ± 14.6 years) with drug-induced liver injury (DILI) (n = 12), autoimmune hepatitis (AIH; n = 13), AIH-DILI overlap (n = 1), viral (n = 9), or cryptogenic liver failure (n = 1). Thirty-one patients recovered spontaneously, 2 patients died, and 1 patient underwent LT. The LiMAx was 197.6 (±68.4) for SR versus 92.33 (±65.0) for NSR (p = 0.0157). Fibrinogen was significantly lower in patients with NSR than in SR patients (209.0 vs. 106.3; p = 0.02). Mean liver stiffness measured by TE was 39.3 for NSR and 17.3 for SR (p = 0.26). KCC was fulfilled in only 4 patients (3 SR, 1 NSR). LiMAx results correlated positively with serum fibrinogen and antithrombin III concentrations and correlated negatively with liver stiffness. No other analyzed factor could differentiate between SR and NSR. Conclusion: Decision-making in ALF remains challenging. LiMAx and fibrinogen might predict the prognosis in patients with nonacetaminophen-induced ALF and in combination could be feasible tools to decide if LT is necessary.

© 2022 S. Karger AG, Basel

References Hadem J, Tacke F, Bruns T, Langgartner J, Strnad P, Denk GU, et al. Etiologies and outcomes of acute liver failure in Germany. Clin Gastroenterol Hepatol. 2012 Jun;10(6):664–9.e2. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, Clinical practice guidelines panel, Wendon, Panel members; Cordoba J, Dhawan A, Larsen FS, et al. EASL clinical practical guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017 May;66(5):1047–81. Bernal W, Cross TJS, Auzinger G, Sizer E, Heneghan MA, Bowles M, et al. Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol. 2009 Feb;50(2):306–13. McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of Kings’s College hospital criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010 Sep;53(3):492–9. McPhail MJW, Farne H, Senvar N, Wendon JA, Bernal W. Ability of King’s college criteria and model for end-stage liver disease scores to predict mortality of patients with acute liver failure: a meta-analysis. Clin Gastroenterol Hepatol. 2016 Apr;14(4):516–25.e5; quiz e43–5. Dechêne A, Sowa JP, Gieseler RK, Jochum C, Bechmann LP, El Fouly A, et al. Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology. 2010;52(3):1008–16. Bechmann LP, Jochum C, Kocabayoglu P, Sowa JP, Kassalik M, Gieseler RK, et al. Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol. 2010 Oct;53(4):639–47. O’Leary JG, Greenberg CS, Patton HM, Caldwell SH. AGA clinical practice update: coagulation in cirrhosis. Gastroenterology. 2019 Jul;157(1):34–43.e1. Buechter M, Kersting S, Gerken G, Kahraman A. Enzymatic liver function measured by LiMAx – a reliable diagnostic and prognostic tool in chronic liver disease. Sci Rep. 2019 Sep 19;9(1):13577. Stockmann M, Lock JF, Malinowski M, Seehofer D, Puhl G, Pratschke J, et al. How to define initial poor graft function after liver transplantation? – a new functional definition by the LiMAx test. Transpl Int. 2010 Oct;23(10):1023–32. Kaffarnik MF, Ahmadi N, Lock JF, Wuensch T, Pratschke J, Stockmann M, et al. Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study. PLoS One. 2017;12(5):e0178237. Jara M, Bednarsch J, Malinowski M, Pratschke J, Stockmann M. Effects of oxaliplatin-based chemotherapy on liver function: an analysis of impact and functional recovery using the LiMAx test. Langenbecks Arch Surg. 2016 Feb;401(1):33–41. Malinowski M, Jara M, Lüttgert K, Orr J, Lock JF, Schott E, et al. Enzymatic liver function capacity correlates with disease severity of patients with liver cirrhosis: a study with the LiMAx test. Dig Dis Sci. 2014 Dec;59(12):2983–91. Buechter M, Gerken G, Hoyer DP, Bertram S, Theysohn JM, Thodou V, et al. Liver maximum capacity (LiMAx) test as a helpful prognostic tool in acute liver failure with sepsis: a case report. BMC Anesthesiol. 2018 Jun 20;18(1):71. Wittauer EM, Oldhafer F, Augstein E, Beetz O, Kleine M, Schumacher C, et al. Porcine model for the study of liver regeneration enhanced by non-invasive 13C-methacetin breath test (LiMAx test) and permanent portal venous access. PLoS One. 2019;14(5):e0217488. Vondran FWR, Schumacher C, Johanning K, Hartleben B, Knitsch W, Wiesner O, et al. Application of the liver maximum function capacity test in acute liver failure: a helpful tool for decision-making in liver transplantation? Case Rep Transplant. 2016;2016:7074636. Köhler T, Pletz MW, Altmann S, Kirchner C, Schwier E, Henzler D, et al. Pericarditis caused by enterococcus faecium with acute liver failure treated by a multifaceted approach including antimicrobials and hemoadsorption. Case Rep Crit Care. 2021;2021:8824050. Lock JF, Kotobi AN, Malinowski M, Schulz A, Jara M, Neuhaus P, et al. Predicting the prognosis in acute liver failure: results from a retrospective pilot study using the LiMAx test. Ann Hepatol. 2013 Aug;12(4):556–62. Canbay A, Tacke F, Hadem J, Trautwein C, Gerken G, Manns MP. Acute liver failure: a life-threatening disease. Dtsch Arztebl Int. 2011 Oct;108(42):714–20. Stockmann M, Lock JF, Riecke B, Heyne K, Martus P, Fricke M, et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg. 2009 Jul;250(1):119–25. Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB. 2010 Mar;12(2):139–46. Fontana RJ, Stravitz RT, Durkalski V, Hanje J, Hameed B, Koch D, et al. Prognostic value of the 13 C-methacetin breath test in adults with acute liver failure and non-acetaminophen acute liver injury. Hepatology. 2021 Aug;74(2):961–72. Lodewick TM, Alizai PH, van Dam RM, Roeth AAJ, Schmeding M, Heidenhain C, et al. Effect of age on liver function in patients undergoing partial hepatectomy. Dig Surg. 2017;34(3):233–40. Tennent GA, Brennan SO, Stangou AJ, O’Grady J, Hawkins PN, Pepys MB. Human plasma fibrinogen is synthesized in the liver. Blood. 2007 Mar 1;109(5):1971–4. Joist JH. AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state. Am J Gastroenterol. 1999 Oct;94(10):2801–3. Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005 Mar;41(3):553–8. Kirchner C, Dirkmann D, Treckmann JW, Paul A, Hartmann M, Saner FH, et al. Coagulation management with factor concentrates in liver transplantation: a single-center experience. Transfusion. 2014 Oct;54(10 Pt 2):2760–8. Lisman T, Kleiss S, Patel VC, Fisher C, Adelmeijer J, Bos S, et al. In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis. Liver Int. 2018 Nov;38(11):1988–96. Jiang W, Huang S, Teng H, Wang P, Wu M, Zhou X, et al. Diagnostic accuracy of point shear wave elastography and transient elastography for staging hepatic fibrosis in patients with non-alcoholic fatty liver disease: a meta-analysis. BMJ Open. 2018 Aug 23;8(8):e021787. Li Y, Huang YS, Wang ZZ, Yang ZR, Sun F, Zhan SY, et al. Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2016 Feb;43(4):458–69. Sharma P, Bansal R, Matin A, Tyagi P, Bansal N, Singla V, et al. Role of transient elastography (fibroscan) in differentiating severe acute hepatitis and acute on chronic liver failure. J Clin Exp Hepatol. 2015 Dec;5(4):303–9. Perazzo H, Veloso VG, Grinsztejn B, Hyde C, Castro R. Factors that could impact on liver fibrosis staging by transient elastography. Int J Hepatol. 2015;2015:624596. Barone M, Iannone A, Brunetti ND, Sebastiani F, Cecere O, Berardi E, et al. Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: pathogenetic mechanisms and clinical relevance. Scand J Gastroenterol. 2015 May;50(5):560–6. Raizner A, Shillingford N, Mitchell PD, Harney S, Raza R, Serino J, et al. Hepatic inflammation may influence liver stiffness measurements by transient elastography in children and young adults. J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):512–7. Chon YE, Kim SU, Park JY, Kim DY, Ahn SH, Han KH, et al. Dynamics of the liver stiffness value using transient elastography during the perioperative period in patients with valvular heart disease. PLoS One. 2014;9(3):e92795. Reuben A, Tillman H, Fontana RJ, Davern T, McGuire B, Stravitz RT, et al. Outcomes in adults with acute liver failure between 1998 and 2013: an observational Cohort Study. Ann Intern Med. 2016 Jun 7;164(11):724–32. Goldberg DS, Forde KA, Carbonari DM, Lewis JD, Leidl KBF, Reddy KR, et al. Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system. Gastroenterology. 2015 Jun;148(7):1353–61.e3. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podestá LG, Villamil FG. MELD is superior to King’s college and clichy’s criteria to assess prognosis in fulminant hepatic failure. Liver Transpl. 2007 Jun;13(6):822–8. Article / Publication Details

First-Page Preview

Received: December 20, 2021
Accepted: February 14, 2022
Published online: February 22, 2022

Number of Print Pages: 9
Number of Figures: 4
Number of Tables: 2

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: https://www.karger.com/DDI

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.